Arvinas Inc reports results for the quarter ended in September 30 - Earnings Summary

Arvinas

30/10/2024 15:19

* Arvinas Inc  ARVN.OQ  reported a quarterly adjusted loss
of 68
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of $-1.18.  The mean expectation of nineteen analysts for the
quarter was for a loss of 96 cents per share. Wall Street
expected results to range from $-1.41 to -11 cents per share.
    * Revenue rose 196% to $102.40 million from a year ago;
analysts
expected $57.42 million. 
    * Arvinas Inc's reported EPS for the quarter was a loss
of 68
cents​.
    * The company reported a quarterly loss of $49.2 million.
    * Arvinas Inc shares had risen by 11.7% this quarter and
lost 33.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 18 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Arvinas Inc is
64.00 
This summary was machine generated from LSEG data October 30 at
03:19 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.96          -0.68          Beat
 Jun. 30 2024      -0.86          -0.49          Beat
 Mar. 31 2024      -1.42          -0.97          Beat
 Dec. 31 2023      -1.27          -2.53          Missed